Related Experiment Video
Updated: Nov 29, 2025

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion
Published on: February 14, 2025
Quality of life after Girdlestone resection arthroplasty
P Zamora-Navas1, F J Estades-Rubio1
1UGC Aparato Locomotor, Hospital Clínico Universitario Virgen de la Victoria, Málaga, España.
Main Aim:
To know the result of the Girdlestone resection arthroplasty in the treatment of the infected hip arthroplasty.
Secondary Aims:
To analyze the effectiveness in the control of pain and infection, the functional outcome and to contrast factors correlated with the final result.
Patients And Methods:
Case series with a total of 17 patients. The control of the infection was assessed according to the presence or absence of sinus, and the clinical status using EuroQol 5D scale, residual pain and limb length discrepancy.
Outcomes:
The most common infecting germ at the time of removal of the arthroplasty was Staphylococcus CN and one patient presented infection by Candida albicans. In 2 patients the draining sinus persisted. The residual dysmetria was 5.24cm. In the EQ-5D scale, the most affected dimensions were mobility, need for help for self-care and ability to carry out activities of daily life. 8 patients maintained, pain levels worse than 4 in the VAS. The variables of dysmetria were correlated inversely with health index (-0,54) and self-perceived general health status (-0,45).
Conclusions:
The Girdlestone resection arthroplasty is an alternative in the treatment of the infected hip arthroplasty. Patient perception is inversely corelated to residual dysmetria. The dysmetria is greater in women and in ages over 65 years.
More Related Videos
07:44Evaluation of Patients' Posture and Gait Profile After Lumbar Fusion Surgery by Video Rasterstereography and Treadmill Gait Analysis
Published on: March 23, 2019
05:07Author Spotlight: Implementing the Enhanced Recovery After Surgery Concept in Rehabilitation Following Anterior Cruciate Ligament Reconstruction
Published on: March 1, 2024